Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hi. Good afternoon, everyone. Thank you all for joining us today. My name is Adi Jayanthi from the health care investment banking team here at JPMorgan.
Just before we get started, you'll see a blue Ask A Question button on your screen. If you do have any questions for the presenters as they're going through, please feel free to submit them through that button and we will try to field those after the presentation. But it's my pleasure to introduce Bryan Stuart today, who's the CEO at Fulcrum Therapeutics. Bryan, over to you.
Thanks, Adi. We appreciate JPMorgan and the opportunity to present here today. So if you follow along with me on the slides today, we'll be making some forward-looking statements. And it really is a pleasure to be able to talk about Fulcrum and our approach and some of the meaningful progress that we've made over the course of the last year.
So our mission at Fulcrum is to treat the root cause of genetically defined rare diseases. And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |